Level of FMB | Total | Level 0 | Level 1 | Level 2 | p value |
---|---|---|---|---|---|
No. of patients | 461 | 74 | 243 | 144 | |
Mean PSA (ng/mL) | 6.6 | 6.5 | 6.5 | 7.0 | 0.672 |
Prostate size (cc) | 36.0 | 37.8 | 35.2 | 36.5 | 0.426 |
Mean % of positive biopsy cores | 20.2 | 13.0 | 19.0 | 26.2 | < 0.001 |
Clinical stage | 0.031 | ||||
cT1 | 257 | 53 | 130 | 73 | |
≥ cT2 | 204 | 21 | 113 | 71 | |
Biopsy Gleason score, No. | < 0.001 | ||||
6 | 197 | 50 | 104 | 43 | |
3 + 4 | 160 | 19 | 84 | 57 | |
4 + 3 | 71 | 2 | 38 | 31 | |
8–10 | 33 | 3 | 17 | 13 | |
Surgical Gleason score, No. | < 0.001 | ||||
6 | 124 | 41 | 65 | 18 | |
3 + 4 | 205 | 26 | 110 | 69 | |
4 + 3 | 99 | 4 | 51 | 44 | |
8–10 | 33 | 3 | 17 | 13 | |
Mean PTV | 8.7 | 3.5 | 8.4 | 11.5 | < 0.001 |
Rate of PSM, N (%) | 50 (10.8%) | 4 (5.4%) | 19 (7.8%) | 27 (18.7%) | 0.001 |